Occurrence of hepatitis in an elderly woman during the treatment of pembrolizumab for right advanced renal pelvis, ureteral cancer, and bladder cancer

Recently, the use of immune checkpoint inhibitors (ICIs) with or without chemotherapeutic agents has been increasing in the treatment for advanced cancer. Here, we report the occurrence of liver failure after the use of pembrolizumab in an 82‐year‐old woman with metastatic liver disease derived from...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:JGH Open
Autors principals: Asatani, Shinya, Kanda, Tatsuo, Honda, Masayuki, Ishii, Tomotaka, Yamana, Yoichiro, Kaneko, Tomohiro, Mizutani, Taku, Takahashi, Hiroshi, Kumagawa, Mariko, Sasaki, Reina, Masuzaki, Ryota, Kanezawa, Shini, Matsumoto, Naoki, Nirei, Kazushige, Yamagami, Hiroaki, Moriyama, Mitsuhiko
Format: Artigo
Idioma:Inglês
Publicat: Wiley Publishing Asia Pty Ltd 2021
Matèries:
Case Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8171158/
https://ncbi.nlm.nih.gov/pubmed/34124393
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jgh3.12554
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars